Loading clinical trials...
Loading clinical trials...
This is a prospective, randomized study designed to compare genotype-guided dosing to usual care in patients with pancreas cancer and colorectal cancer who are UGT1A1 intermediate metabolizers (\*1/\*...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Reema A. Patel
NCT07417488 · Colorectal Cancer, Small Bowel Adenocarcinoma
NCT07300150 · Colorectal Cancer, Pancreatic Cancer, and more
NCT06728072 · Colorectal Cancer, CRC
NCT06205836 · Colorectal Cancer
NCT06160323 · Pancreatic Cancer Non-resectable, Tumor Pancreas, and more
University of Kentucky
Lexington, Kentucky
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions